Engineering tolerance using biomaterials to target and control antigen presenting cells. Tostanoski LH, Gosselin EA, Jewell CM Discov Med. 2016 May; 21(117):403-10. PMID: 27355336. Abstract CommentRecommendBookmarkWatch
